Integration Of Active Specific Immunotherapy And Cell Therapy Into The Protocols Of Biomedical Management Of Interstitial Pneumonia With Autoimmune Features

Integration-Of-Active-Specific-Immunotherapy-And-Cell-Therapy-Into-The-Protocols-Of-Biomedical-Management-Of-Interstitial-Pneumonia-With-Autoimmune-Features-–-A-case-study

Integration Of Active Specific Immunotherapy And Cell Therapy Into The Protocols Of Biomedical Management Of Interstitial Pneumonia With Autoimmune Features

Dr. Roni L. Moya, Prof. Dr. Mike Chan, Prof. Dr. Michelle Wong and Dr. Dmytro Klokol.

Clinical and Medical Reports, ISSN: 2516-5283, doi: 10.15761/CMR.1000158, Volume 3: 1-5, 9 Nov 2020.

Published URL: https://www.oatext.com/integration-of-active-specific-immunotherapy-and-cell-therapy-into-the-protocols-of-biomedical-management-of-interstitial-pneumonia-with-autoimmune-features-a-case-study.php

Download PDF | EN

Download PDF | CN

上一篇Melatonin, Pineal Gland And Sleep Disorders: From Theory To Practice 下一篇 Transfer Factors Or Dialyzable Leucocyte Extracts As Immune-Modulating Peptides: A Conceptual Review On Broad Spectrum Of Therapeutic Areas, Immunologic And Clinical Response, Trends And Perspectives